Showing results (291-300 of 309) with videos related to
Sort By:
Pageof 31
Plos One|October 8, 2014
Peyer's patches and mesenteric lymph nodes cooperatively promote enteropathy in a mouse model of food allergyHaruyo Nakajima-Adachi, Akira Kikuchi, Yoko Fujimura, et al.Oncogene|March 3, 2020
XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovaryRyo Tamura, Kosuke Yoshihara, Hirofumi Nakaoka, et al.Hepatology (Baltimore, Md.)|February 7, 2013
Wnt5a signaling mediates biliary differentiation of fetal hepatic stem/progenitor cells in miceKei Kiyohashi, Sei Kakinuma, Akihide Kamiya, et al.Plos One|October 15, 2011
MMP-10/stromelysin-2 promotes invasion of head and neck cancerElsayed Mohamed Deraz, Yasusei Kudo, Maki Yoshida, et al.Leukemia Research|November 16, 2013
Significance of CD66c expression in childhood acute lymphoblastic leukemiaNobutaka Kiyokawa, Kazutoshi Iijima, Osamu Tomita, et al.British Journal of Haematology|October 31, 2009
Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemiaKazuyuki Matsuda, Kazuo Sakashita, Chiaki Taira, et al.Breast Cancer (Tokyo, Japan)|August 14, 2024
Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese CommunityMitsuhiro Watanabe, Shinya Fujiki, Yuji Okura, et al.Cancer Science|February 26, 2022
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinomaTomomi Egawa-Takata, Yutaka Ueda, Kimihiko Ito, et al.Pediatric Research|December 3, 2008
Correlation of clinical features with the mutational status of GM-CSF signaling pathway-related genes in juvenile myelomonocytic leukemiaNao Yoshida, Hiroshi Yagasaki, Yinyan Xu, et al.Integrative Cancer Therapies|March 29, 2025
Efficacy of Rikkunshito on Chemotherapy-Induced Nausea and Vomiting in Patients With Uterine Corpus or Cervical Cancer Treated With Cisplatin-Based Regimen-Placebo-controlled, Double-Blind, Randomized Confirmatory Study (JORTC-KMP03)Yosuke Konno, Shunsuke Ohnishi, Shinichiro Minobe, et al.Pageof 31